SYED ARFEEN: Open Payments
NPI 1245298702 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 18 payments from 7 companies in 2025. Trend: 2023 $54 · 2024 $87 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $237 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: COBENFY, TRINTELLIX, CAPLYTA, ARISTADA, HETLIOZ, REXULTI, ABILIFY ASIMTUFII, FANAPT.
Industry payments across NC — which companies pay providers there.
